Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Green

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Plos One|March 25, 2015
Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's diseaseStewart F Graham, Olivier P Chevallier, Christopher T Elliott, et al.
Metabolites|October 2, 2019
Application of <sup>1</sup>H-NMR Metabolomics for the Discovery of Blood Plasma Biomarkers of a Mediterranean DietShirin Macias, Joseph Kirma, Ali Yilmaz, et al.
Metabolites|May 15, 2019
The Health Promoting Bioactivities of <i>Lactuca sativa</i> can be Enhanced by Genetic Modulation of Plant Secondary MetabolitesHammad Ismail, Anna L Gillespie, Danielle Calderwood, et al.
Nutricion Hospitalaria|June 29, 2014
Effects of Undaria pinnatifida, Himanthalia elongata and Porphyra umbilicalis extracts on in vitro α-glucosidase activity and glucose diffusionAdriana R Schultz Moreira, Alba Garcimartín, Sara Bastida, et al.
Biological Chemistry|January 15, 2004
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1Brian D Green, Victor A Gault, Nigel Irwin, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2005
A novel, long-acting agonist of glucose-dependent insulinotropic polypeptide suitable for once-daily administration in type 2 diabetesNigel Irwin, Brian D Green, Mark H Mooney, et al.
Diabetes|July 28, 2005
Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetesVictor A Gault, Nigel Irwin, Brian D Green, et al.
Cardiovascular Diabetology|April 16, 2016
Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodellingEmma Robinson, Mitchel Tate, Samuel Lockhart, et al.
Biochimica Et Biophysica Acta|June 12, 2016
Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brainStewart F Graham, Praveen K Kumar, Trent Bjorndahl, et al.
Cells|September 28, 2021
Assessment and Validation of <i>Globodera pallida</i> as a Novel In Vivo Model for Studying Alzheimer's DiseaseNorah A Althobaiti, Farid Menaa, Aishah E Albalawi, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Plos One|March 25, 2015
Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's diseaseStewart F Graham, Olivier P Chevallier, Christopher T Elliott, et al.
Metabolites|October 2, 2019
Application of <sup>1</sup>H-NMR Metabolomics for the Discovery of Blood Plasma Biomarkers of a Mediterranean DietShirin Macias, Joseph Kirma, Ali Yilmaz, et al.
Metabolites|May 15, 2019
The Health Promoting Bioactivities of <i>Lactuca sativa</i> can be Enhanced by Genetic Modulation of Plant Secondary MetabolitesHammad Ismail, Anna L Gillespie, Danielle Calderwood, et al.
Nutricion Hospitalaria|June 29, 2014
Effects of Undaria pinnatifida, Himanthalia elongata and Porphyra umbilicalis extracts on in vitro α-glucosidase activity and glucose diffusionAdriana R Schultz Moreira, Alba Garcimartín, Sara Bastida, et al.
Biological Chemistry|January 15, 2004
Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1Brian D Green, Victor A Gault, Nigel Irwin, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 2005
A novel, long-acting agonist of glucose-dependent insulinotropic polypeptide suitable for once-daily administration in type 2 diabetesNigel Irwin, Brian D Green, Mark H Mooney, et al.
Diabetes|July 28, 2005
Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetesVictor A Gault, Nigel Irwin, Brian D Green, et al.
Cardiovascular Diabetology|April 16, 2016
Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodellingEmma Robinson, Mitchel Tate, Samuel Lockhart, et al.
Biochimica Et Biophysica Acta|June 12, 2016
Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brainStewart F Graham, Praveen K Kumar, Trent Bjorndahl, et al.
Cells|September 28, 2021
Assessment and Validation of <i>Globodera pallida</i> as a Novel In Vivo Model for Studying Alzheimer's DiseaseNorah A Althobaiti, Farid Menaa, Aishah E Albalawi, et al.
Pageof 12